BSE Live
Nov 28, 16:01Prev. Close
147.75
Open Price
147.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:57Prev. Close
147.09
Open Price
144.25
Bid Price (Qty.)
135.42 (5)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indo US Bio-Tech (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 8.27 | 8.07 | 4.18 | |
| Diluted EPS (Rs.) | 8.27 | 8.07 | 4.18 | |
| Cash EPS (Rs.) | 6.03 | 8.53 | 4.55 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 42.01 | 35.17 | 27.10 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 42.01 | 35.17 | 27.10 | |
| Revenue from Operations/Share (Rs.) | 54.61 | 66.10 | 65.53 | |
| PBDIT/Share (Rs.) | 7.56 | 8.82 | 6.48 | |
| PBIT/Share (Rs.) | 7.08 | 8.40 | 6.13 | |
| PBT/Share (Rs.) | 5.79 | 6.48 | 4.74 | |
| Net Profit/Share (Rs.) | 5.52 | 8.07 | 4.18 | |
| NP After MI And SOA / Share (Rs.) | 5.52 | 8.07 | 4.18 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 13.85 | 13.34 | 9.89 | |
| PBIT Margin (%) | 12.95 | 12.70 | 9.35 | |
| PBT Margin (%) | 10.61 | 9.79 | 7.22 | |
| Net Profit Margin (%) | 10.11 | 12.21 | 6.37 | |
| NP After MI And SOA Margin (%) | 10.11 | 12.21 | 6.37 | |
| Return on Networth/Equity (%) | 13.14 | 22.95 | 15.41 | |
| Return on Capital Employed (%) | 14.97 | 19.93 | 20.70 | |
| Return on Assets (%) | 9.10 | 11.21 | 7.30 | |
| Total Debt/Equity (X) | 0.33 | 0.50 | 0.48 | |
| Asset Turnover Ratio (%) | 1.01 | 91.77 | 114.59 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 3.81 | 2.10 | 1.91 | |
| Quick Ratio (X) | 1.91 | 1.45 | 1.36 | |
| Inventory Turnover Ratio (X) | 0.00 | 3.38 | 4.35 | |
| Dividend Payout Ratio (NP) (%) | 2.99 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 2.74 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 97.01 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 97.26 | 0.00 | 0.00 | |
| Coverage Ratios | ||||
| Interest Coverage Ratios (%) | 5.90 | 4.37 | 4.40 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.90 | 4.37 | 4.40 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 74.67 | 30.20 | 38.83 | |
| EV/Net Operating Revenue (X) | 1.49 | 0.75 | 0.98 | |
| EV/EBITDA (X) | 10.77 | 5.64 | 9.87 | |
| MarketCap/Net Operating Revenue (X) | 1.24 | 0.49 | 0.78 | |
| Retention Ratios (%) | 97.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.61 | 0.93 | 1.90 | |
| Price/Net Operating Revenue | 1.24 | 0.49 | 0.78 | |
| Earnings Yield | 0.08 | 0.25 | 0.08 |
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017